Human Microglia–Like Cells Differentiated from Monocytes with GM-CSF and IL-34 Show Phagocytosis of α-Synuclein Aggregates and C/EBPβ-Dependent Proinflammatory Activation
Mol Neurobiol (2024). https://doi.org/10.1007/s12035-024-04289-z
Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson’s Disease Diagnosis and Duration
Journal of Parkinson’s Disease. 2024;14(4):667-679. doi:10.3233/JPD-230390
Synthetic β-sheets mimicking fibrillar and oligomeric structures for evaluation of spectral X-ray scattering technique for biomarker quantification
Cell Biosci (2024) 14 (1), 26 DOI: 10.1186/s13578-024-01208-6
α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay
Ann Neurol (2024) 95 (6), 1173-1177 DOI: 10.1002/ana.26917
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Acta Neuropathol (2024) 147 (1), 14 DOI: 10.1007/s00401-023-02657-y
Nanoplastics exacerbate Parkinson's disease symptoms in C. elegans and human cells
J Hazard Mater (2024) 465, 133289 DOI: 10.1016/j.jhazmat.2023.133289
Autoclave treatment fails to completely inactivate DLB alpha-synuclein seeding activity
Biochemistry and Biophysics Reports (2023) 34, 101446 DOI: 10.1016/j.bbrep.2023.101446
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
J. Vis. Exp. (196), e65453, doi:10.3791/65453 (2023).
Oligomeric and Fibrillar α-Synuclein Display Persistent Dynamics and Compressibility under Controlled Confinement
ACS Chem Neurosci (2023) 14 (21), 3905-3912 DOI: 10.1021/acschemneuro.3c00470
Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson's Disease
J Parkinsons Dis (2023) 13 (5), 841-844 DOI: 10.3233/JPD-230065